Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 June 2025

European Medicines Agency summary of the PRAC meeting concluding that non-arteritic anterior ischaemic optic neuropathy is a very rare side effect of semaglutide medicines, affecting up to 1 in 10,000 people.